Tempus AI与血液癌联合组织Blood Cancer United®今日宣布达成战略合作，双方将共同构建全球规模领先的儿童急性髓系白血病真实世界数据登记库。这一创新性数据平台旨在整合多中心临床诊疗信息，通过人工智能技术深度挖掘真实世界证据，为儿科血液肿瘤的精准治疗与药物研发提供关键数据支撑。
该项目将收录来自全美顶尖儿童医院的匿名化临床数据，涵盖患者诊疗路径、基因组学特征、治疗反应及长期预后等多维度信息。通过建立标准化数据采集流程，登记库有望突破传统临床试验的局限性，为罕见病研究提供更全面的真实世界洞察。
此次合作标志着真实世界证据在儿科罕见癌症领域应用的重要突破。Tempus AI领先的AI技术与Blood Cancer United®的临床网络资源相结合，将加速儿童急性髓系白血病治疗方案的优化，推动个性化医疗发展。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.